Cargando…
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
The aim of this study was to investigate the efficacy of Intravitreal Injection of Bevacizumab (IVB) in patients with Central Serous Chorioretinopathy (CSC) compared to the control group, after four months of injection. In this study, 30 eyes of 30 patients with CSC, who were in the age range of 23...
Autores principales: | Maleki, Alireza, Nezamdust, Zahra, Salari, Amirmasoud, Ahmadi, Seyed Sajad, Sabbaghi, Hamideh, Bagherzadeh, Omid, Ataollahi, Alireza, Yaseri, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6229672/ https://www.ncbi.nlm.nih.gov/pubmed/30505869 |
Ejemplares similares
-
Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
por: Entezari, Morteza, et al.
Publicado: (2012) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019) -
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
por: Lim, Ji Won, et al.
Publicado: (2010) -
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)